"Which one should I choose, a glucagon-like peptide-1 receptor agonist or a sodium-glucose cotransporter 2 inhibitor? Or maybe both?"

Eur J Intern Med. 2022 Apr:98:125-127. doi: 10.1016/j.ejim.2021.12.010. Epub 2021 Dec 27.
No abstract available

Keywords: Cardiovascular disease; GLP-1RA; SGLT-2 inhibitor.

Publication types

  • Letter
  • Comment

MeSH terms

  • Glucagon-Like Peptide-1 Receptor* / agonists
  • Glucose
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • Sodium
  • Glucose